Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Laird Norton Wetherby Wealth Management LLC

Laird Norton Wetherby Wealth Management LLC lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 13.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,141 shares of the real estate investment trust’s stock after selling 1,550 shares during the period. Laird Norton Wetherby Wealth Management LLC’s holdings in Healthpeak Properties were worth $206,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in DOC. JPMorgan Chase & Co. lifted its position in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares during the period. Geode Capital Management LLC lifted its position in Healthpeak Properties by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust’s stock worth $371,168,000 after buying an additional 638,012 shares during the period. Principal Financial Group Inc. lifted its position in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in Healthpeak Properties by 10.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust’s stock worth $350,021,000 after buying an additional 1,651,235 shares during the period. Finally, Centersquare Investment Management LLC lifted its position in Healthpeak Properties by 3.7% during the fourth quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust’s stock worth $227,339,000 after buying an additional 398,770 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $17.72 on Friday. The stock’s 50 day moving average price is $18.78 and its 200 day moving average price is $20.06. The firm has a market capitalization of $12.31 billion, a PE ratio of 50.62, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $16.90 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. Healthpeak Properties’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.45 EPS. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a dividend, which will be paid on Friday, May 30th. Investors of record on Tuesday, May 20th will be given a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 305.00%.

Insider Buying and Selling

In other Healthpeak Properties news, CEO Scott M. Brinker acquired 2,750 shares of the company’s stock in a transaction on Friday, May 9th. The shares were bought at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the acquisition, the chief executive officer now directly owns 204,613 shares of the company’s stock, valued at $3,558,220.07. This trade represents a 1.36% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Tommy G. Thompson acquired 5,700 shares of the company’s stock in a transaction on Friday, May 9th. The shares were acquired at an average price of $17.36 per share, for a total transaction of $98,952.00. Following the completion of the acquisition, the director now directly owns 138,513 shares in the company, valued at $2,404,585.68. The trade was a 4.29% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 23,987 shares of company stock valued at $422,141. Corporate insiders own 0.23% of the company’s stock.

Analyst Upgrades and Downgrades

DOC has been the topic of several recent analyst reports. Wedbush reduced their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research report on Monday, April 28th. Argus reiterated a “buy” rating and set a $25.00 target price on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Evercore ISI cut their price objective on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. Finally, StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Thursday, May 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus target price of $23.45.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.